Enantioselective synthesis of some 6-deoxy-halodeoxy inositol derivatives

Tetrahedron Letters

Volumn 40, Issue 36, 1999, Pages 6531-6534

  Da Silva, Adilson David ^a   Benicio, Aloisio Antonio A ^a   Gero, Stéphane D ^b  

^a FEDERAL UNIVERSITY OF JUIZ DE FORA   (Brazil)

^b CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

INOSITOL 1,4,5 TRISPHOSPHATE DERIVATIVE; INOSITOL DERIVATIVE;

ARTICLE; ENANTIOMER; HALOGENATION; OPTICAL ROTATION; REACTION ANALYSIS; STEREOCHEMISTRY; SYNTHESIS;

EID: 0033520257     PISSN: 00404039     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0040-4039(99)01307-6     Document Type: Article

References (25)

1. (a) Abdel-Latif, A. A. Pharmacol. Rev. 1986, 38, 227.
2. (b) Michell, R. H.; Drummond, A. H.; Downes, C. P., Eds.; Academic Press: London, 1989.
3. (c) Fisher, S. K.; Agranoff, B. W. J. Neurochem. 1987, 48, 999.
4. (d) Drummond, A. H. Trends Pharmacol. Sci. 1987, 8, 129.
5. (a) Qiao, L. X.; Nan, F. J.; Kunkel, M.; Gallegos, A.; Powis, G.; Kozikowski, A. P. J. Med. Chem. 1998, 41(18), 3303.
6. (b) Brunn, G.; Fauq, A. H.; Chow, S.; Kozikowski, A. P.; Gallegos, A.; Powis, G. Cancer Chemother. Pharmacol. 1994, 35(1), 71.
7. (c) Powis, G.; Workman, P. Anti-Cancer Drug Design 1994, 9(4), 263.
8. (d) Powis, G.; Phil, D. Cancer and Metastasis Reviews 1994, 13(1), 91.
9. (a) Aneja, S. G.; Ivanova, P. T.; Aneja, R. Bioorg. Med. Chem. Lett. 1998, 8(9), 1061.
10. (b) Richards, F. M.; Wyckoff, H. The Enzymes; Boyer, P. D., Ed.; Academic Press: NY and London, 1971; 3rd ed., Vol. 4, p. 647.
11. (a) Dahl, J.; Jurczak, A.; Cheng, L. A.; Baker, D. C.; Benjamin, T. L. J. Virol. 1998, 72(4), 3221.
12. (b) Kozikowski, A. P.; Fauq, A. H.; Powis, G.; Melder, D. C. J. Am. Chem. Soc. 1990, 112, 4528.
13. Safrany, S. T.; Wojcikiewicz, R. J. H.; Strupish, J.; Nahorski, S. R.; Dubreuil, D.; Cleophax, J.; Gero, S. D.; Potter, B. V. L. FEBS Lett. 1991, 278, 252.
14. Vieira de Almeida, M.; Dubreuil, D.; Cleophax, J.; Verre-Sebrié, C.; Pipelier, M.; Prestat, G.; Vass, G.; Gero, S. D. Tetrahedron 1999, 55, 7251.
15. (a) Lowe, G.; McPhee, F. J. Chem. Soc., Perkin Trans. 1 1992, 1249.
16. (b) Sawyer, D. A.; Potter, B. V. L. J. Chem. Soc., Perkin Trans. 1 1992, 923.
17. (c) Moyer, J. D.; Reizes, O.; Ahir, S.; Jiang, C.; Malinowski, N.; Baker, D. C. Mol. Pharmacol. 1989, 33, 683.
18. Thornber, C. W. Chem. Soc. Rev. 1979, 8, 563.
19. Cleophax, J.; Dubrueil, D.; Gero, S. D.; Loupy, A.; Vieira de Almeida, M.; Da Silva, A. D.; Vass, G. Bioorg. Med. Chem. Lett. 1995, 5, 831.
20. 2 requires: C, 54.19; H, 4.90%).
21. 6-F=9.4 Hz).
22. 5F requires: C, 43.37; H, 6.67%).
23. Dubreuil, D.; Cleophax, J.; Vieira de Almeida, M.; Verre-Sebrié, C.; Liaigre, J.; Vass, G.; Gero, S. D. Tetrahedron 1997, 53, 16747.
24. 6ax-1=12 Hz).
25. 1H correlations were performed.